IN8bio, Inc. (INAB) Social Stream
IN8BIO INC (INAB) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering INAB.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 2 | $19 | $12 | $15.5 | $1.69 | 817.16% |
| 2022-05-18 | 2 | $9 | $9 | $9 | $1.69 | 432.54% |
| 2022-08-30 | 2 | $14 | $9 | $11.5 | $1.69 | 580.47% |
| 2022-11-11 | 1 | $14 | $14 | $14 | $1.69 | 728.4% |
| 2023-11-13 | 3 | $14 | $8 | $11.333 | $1.69 | 570.59% |
| 2023-12-12 | 2 | $14 | $8 | $11 | $1.69 | 550.89% |
The Trend in the Analyst Price Target
INAB's average price target has moved down $4.5 over the prior 28 months.
INAB reports an average of 732.9% for its upside potential over the past 37 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-31 | 2 | 14 | 8 | 11.000 | 1.300 | 746.15% |
| 2023-04-05 | 3 | 14 | 8 | 11.333 | 1.180 | 860.42% |
| 2023-05-16 | 3 | 14 | 8 | 11.333 | 2.670 | 324.46% |
| 2023-08-11 | 3 | 14 | 8 | 11.333 | 1.170 | 868.63% |
| 2023-12-12 | 2 | 14 | 8 | 11.000 | 1.635 | 572.78% |
INAB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 19 months, INAB's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, IN8BIO INC's number of analysts covering the stock is higher than 27.19% of them.
- INAB has a greater upside potential (average analyst target price relative to current price) than 1043.29% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, IN8BIO INC's average analyst price target is greater than 142.18% of them.
- INAB has a lower variance in analysts' estimates than -157.1% of Pharmaceutical Products stocks.
Stocks similar to IN8BIO INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CGTX, OKYO, and MNPR.
View All Top Stocks by Price Target
Is INAB a Buy, Hold or Sell? See the POWR Ratings now!